We also observed a significant improvement in oral disposition index, a dynamic measure of pancreatic beta cell function that has been adjusted for the influence of prevailing insulin sensitivity level, in the high GLP-1 prediabetes group treated with linagliptin. The gene discussed is INS; the disease is prediabetes syndrome.